Essential Profile
A clear gut microbiome baseline: composition, diversity and method notes.
Gut microbiome testing
A gut microbiome test reads the microbial community of your gut from a stool sample: which bacterial groups are present, in what proportions, and how diverse the community is. GutX™ is the VAMS BIOME gut test — sequencing-derived, interpreted through VAMS ATLAS™, with a confidence indicator on every output.
VAMS BIOME reports are designed for educational microbiome interpretation, wellness context, and longitudinal awareness. They are not a substitute for personal medical care.
A gut microbiome test uses a stool sample to profile the gut microbiota — the community of bacteria and, depending on the method, other microbes living in the large intestine. Sequencing reads the genetic material in the sample; a bioinformatics pipeline assigns those reads to microbial groups and estimates their relative abundance and the diversity of the community. Depending on the selected sequencing depth and report package, your GutX™ report may include composition summaries, diversity context, key taxa patterns, functional-potential context, ATLAS™ interpretation layers, confidence indicators and longitudinal comparison when you retest.
The report describes microbial patterns and interpretation context. It does not convert microbiome results into personal medical decisions.
People search for a "gut health test", a "gut bacteria test", a "gut flora test" or a "stool microbiome test" and usually mean the same thing: a sequencing-based profile of the gut microbial community from a stool sample. Older terms like "gut flora" describe the same community that microbiome science now calls the gut microbiota. What differs between providers is the method (marker-gene 16S versus shotgun metagenomics, and RNA-based metatranscriptomics in research settings), the reference cohort, and how honestly uncertainty is reported. A gut microbiome test is not a stool pathology test, a food-intolerance test or a colonoscopy, and it does not diagnose digestive conditions.
Responsible microbiome interpretation starts with clear boundaries. Research describes many associations between gut microbial patterns and aspects of health, and an association is not a cause. A gut microbiome report organises sequencing-derived information; it does not diagnose, and it is not a replacement for personal medical care.
GutX™ is the VAMS BIOME gut microbiome test. It combines at-home stool collection, sequencing-derived microbial analysis and VAMS ATLAS™ interpretation options so you can move from raw microbial data toward structured report context — with the method stated on every output, a confidence indicator beside every score, and outputs withheld where the data cannot support them.
Collection is designed for a normal home, not a clinic: you collect the appropriate sample at home using the supplied kit, then register and securely return it for processing. The collection kit is being finalised, so its contents are not described here, and VAMS BIOME does not publish a turnaround time yet.
Follow the instructions in your kit exactly; they are the source of truth for timing and handling.
VAMS BIOME keeps two choices separate. Your package controls interpretation depth. Sequencing depth controls biological resolution. This keeps the choice easy to understand while preserving the scientific method details.
A clear gut microbiome baseline: composition, diversity and method notes.
Recommended package for structured ATLAS™ interpretation, including the Gut Foundation Pack, core Scores, Panels and confidence indicators.
Expanded interpretation, eligible Insight Packs, and longitudinal readiness where supported.
Essential Profile, ATLAS Core, and ATLAS Plus are not renamed versions of 16S, WGS, and MetaT. GutX™ is not open for orders yet, and no prices are published.
Sequencing depth changes what type of microbial information can be generated from a stool sample. The three methods are not a ladder — each answers a different question.
Reads the 16S rRNA gene. A strong, cost-efficient baseline for bacterial composition and diversity, typically at genus level. Asks: who is there?
Shotgun metagenomics reads all the DNA in the sample. Broader taxonomic resolution — species where coverage permits — plus functional-potential context; for GutX™, scoped for professional and research work and quoted per engagement. Asks: what could they do?
Metatranscriptomics reads RNA for activity context at the sampled timepoint. A planned layer in the VAMS BIOME architecture, not yet available. Asks: what are they doing now?
VAMS ATLAS™ organises sequencing-derived microbiome features into structured report layers. The Gut Foundation Pack provides the core ecosystem interpretation. Scores summarise focused microbial patterns. Panels group related scores into biological domains. Insight Packs add deeper thematic interpretation where compatible. Reference-cohort context is stated as an association, not a clinical reference interval, and every output carries a confidence indicator.
Scores and Panels are report outputs. They are not sold as standalone products.
A VAMS BIOME report is designed to make sequencing-derived results easier to navigate. The illustrative sample report shows composition, diversity context, ATLAS™ layers, confidence indicators, method notes and sample-specific limitations. It is illustrative, not a real result.
Sample report previews use illustrative data. Actual report content depends on the selected product, package, sequencing depth, data quality, and compatible interpretation layers.
GutX™ is the focused starting point for gut microbiome context. A bundle may be more useful when you want to read gut patterns alongside another ecosystem in one reporting structure. Cross-ecosystem panels describe concordance and context; they never infer causation between sites.
Focused gut microbiome context.
Explore GutX™GutX™ + OralX™ — mouth and gut read together.
View bundleEvery multi-ecosystem pathway and what each one combines.
Compare bundlesThe gut-health Insights hub explains the gut–brain axis and how the gut microbiome relates to digestion, in evidence-aware language. The sequencing explainer sets out what 16S and WGS each read, and the packages page explains what each interpretation package includes.
Further reading
A gut microbiome test uses a stool sample to summarise microbial composition and related sequencing-derived features from the gut ecosystem. The report may include diversity context, key taxa patterns, method notes and ATLAS™ interpretation layers depending on the selected package and sequencing depth.
In everyday use, yes: "gut health test" usually refers to a sequencing-based gut microbiome profile from a stool sample. GutX™ is that kind of test. It is not a clinical health assessment, a stool pathology test or a food-intolerance test, and it does not diagnose digestive conditions.
At home, using the supplied kit and its step-by-step instructions. You register the kit, collect a small sample, and securely return it for processing. Follow the instructions in your kit exactly; they are the source of truth for handling.
A gut microbiome test is the category. GutX™ is the VAMS BIOME gut microbiome test, designed with package-first configuration, declared sequencing methods, ATLAS™ interpretation, confidence indicators and secure digital report access.
16S Foundation™ reads one marker gene and gives a cost-efficient bacterial composition and diversity baseline, typically at genus level. WGS Advanced™ reads all the DNA in the sample for broader taxonomic resolution — species where coverage permits — and functional-potential context. They answer different questions; neither is simply "better".
VAMS BIOME does not publish a turnaround time yet. Timing depends on the sequencing method and on laboratory processing.
The cost of a gut microbiome test depends on the sequencing method and on how much interpretation the report includes. GutX™ is not open for orders yet and VAMS BIOME has not published prices; the packages page explains what each package includes.
No. GutX™ describes microbial composition and diversity in the context of a reference cohort. It does not diagnose IBS, IBD or any condition, does not identify the cause of symptoms, and is not a substitute for personal medical care. Please discuss symptoms with a qualified professional.
Yes. Repeat testing supports longitudinal comparison when the same reporting structure and compatible analysis pathway are available. VAMS BIOME runs repeat timepoints on pinned pipeline versions so that a later result is genuinely comparable with an earlier one.
No. VAMS BIOME reports are designed for educational microbiome interpretation, wellness context, and longitudinal awareness. They are not a substitute for personal medical care.
Explore the GutX™ product page, choose a package-first pathway, or use the quiz if you are not sure where to begin.